Post-BMT outcome
Case . | CD34 selected . | Post-BMT . | Outcome . | ||
---|---|---|---|---|---|
G-CSF . | IFN . | Bisphosphonate . | |||
1 | Yes | No | No | From day 358 | Well day 1363 |
2 | No | No | No | No | Progression day 501 |
3 | No | No | No | No | Renal failure day 353; progression day 491 |
4 | Yes | No | From day 115 | No | Progression day 640 |
5 | Yes | No | From day 814 | From day 546 | Well day 1206 |
6 | No | No | Days 181-467 | From day 181 | Progression day 658 |
7 | Yes | No | Days 106-730 | From day 54 | Well day 1104 |
8 | Yes | No | Days 93-397 | From day 429 | Progression day 597 |
9 | Yes | No | Days 62-206 | No | Progression day 225 |
10 | Yes | No | Days 260-376 | Days 30-376 | Progression day 390 |
11 | No* | Yes | No | No | Progression and consent withdrawn day 33 |
12 | No | Yes | No | From day 545 | Progression day 102 |
13 | No | No | Days 253-620 | From day 30 | Well day 783 |
14 | No | No | No | No | Well day 333; lost to follow-up since |
15 | No* | Yes | Days 72-309 | From day 72 | Well day 693 |
16 | No | No | From day 42 | From day 42 | Well day 665 |
17 | Yes | No | Days 49-124 | From day 94 | Well day 648 |
18 | No | Yes | Days 167-451 | No | Progression day 451 |
19 | No | Yes | No | No | Well day 494 |
20 | Yes | Yes | No | No | Well day 404 |
21 | Yes | Yes | No | No | Well day 105; lost to follow-up since |
22 | Yes | Yes | No | No | Well day 384 |
23 | Yes | Yes | From day 119 | From day 147 | Well day 370 |
24 | No | Yes | Days 129-312 | No | Well day 341 |
25 | No* | Yes | Days 105-231 | No | Progression day 272 |
26 | No* | Yes | No | From day 282 | Well day 309 |
27 | Yes | Yes | No | No | Well day 246 |
28 | Yes | Yes | No | No | Well day 237 |
29 | Yes | Yes | No | No | Well day 236 |
30 | Yes | Yes | Days 89-117 | No | Well day 214 |
31 | No* | Yes | No | No | Well day 111 |
32 | Yes | Yes | No | No | Well day 66 |
Case . | CD34 selected . | Post-BMT . | Outcome . | ||
---|---|---|---|---|---|
G-CSF . | IFN . | Bisphosphonate . | |||
1 | Yes | No | No | From day 358 | Well day 1363 |
2 | No | No | No | No | Progression day 501 |
3 | No | No | No | No | Renal failure day 353; progression day 491 |
4 | Yes | No | From day 115 | No | Progression day 640 |
5 | Yes | No | From day 814 | From day 546 | Well day 1206 |
6 | No | No | Days 181-467 | From day 181 | Progression day 658 |
7 | Yes | No | Days 106-730 | From day 54 | Well day 1104 |
8 | Yes | No | Days 93-397 | From day 429 | Progression day 597 |
9 | Yes | No | Days 62-206 | No | Progression day 225 |
10 | Yes | No | Days 260-376 | Days 30-376 | Progression day 390 |
11 | No* | Yes | No | No | Progression and consent withdrawn day 33 |
12 | No | Yes | No | From day 545 | Progression day 102 |
13 | No | No | Days 253-620 | From day 30 | Well day 783 |
14 | No | No | No | No | Well day 333; lost to follow-up since |
15 | No* | Yes | Days 72-309 | From day 72 | Well day 693 |
16 | No | No | From day 42 | From day 42 | Well day 665 |
17 | Yes | No | Days 49-124 | From day 94 | Well day 648 |
18 | No | Yes | Days 167-451 | No | Progression day 451 |
19 | No | Yes | No | No | Well day 494 |
20 | Yes | Yes | No | No | Well day 404 |
21 | Yes | Yes | No | No | Well day 105; lost to follow-up since |
22 | Yes | Yes | No | No | Well day 384 |
23 | Yes | Yes | From day 119 | From day 147 | Well day 370 |
24 | No | Yes | Days 129-312 | No | Well day 341 |
25 | No* | Yes | Days 105-231 | No | Progression day 272 |
26 | No* | Yes | No | From day 282 | Well day 309 |
27 | Yes | Yes | No | No | Well day 246 |
28 | Yes | Yes | No | No | Well day 237 |
29 | Yes | Yes | No | No | Well day 236 |
30 | Yes | Yes | Days 89-117 | No | Well day 214 |
31 | No* | Yes | No | No | Well day 111 |
32 | Yes | Yes | No | No | Well day 66 |
BMT, bone marrow transplant; BM, bone marrow; PBSC, peripheral blood stem cell; G-CSF, granulocyte colony-stimulating factor; IFN, interferon.
Transplanted with BM and PBSC.